register

Leadership & Management

‘We don’t need to choose’: The best advice that shaped Organon’s Asia Pacific leader – IWD 2025

Health Industry Hub | March 4, 2025 |

The road to true gender equity is neither straight nor smooth – it is carved by persistence, resilience, and an unwavering belief that diversity, equity, and inclusion (DE&I) is not an aspiration but a necessity.

Ahead of International Women’s Day (IWD) on 7 March, Anna Komarova, HR Lead for Organon’s Asia Pacific Cluster, reflects on the shifting tides of DE&I and the unrelenting momentum required to drive real change.

“All our leaders across the world have signed the pledge to diversity and inclusion,” Komarova shared.

This year’s IWD theme, For ALL women and girls: Rights. Equality. Empowerment, strikes a personal chord with Komarova.

“There is a statement in the minds of females that we need to choose…,” she explained, reflecting on the pivotal career advice that shaped her path to leadership success.

Leading in the vast and culturally intricate Asia Pacific region, Komarova revealed her “recipe” to being an influential female leader while staying authentic and true to her values.

From leadership development initiatives to policies that recognise the intersection of work, health, and life, Organon is dismantling barriers that have long dictated who rises and who remains unseen.

But progress is rarely linear. As DE&I initiatives face a level of backlash globally, Komarova remains resolute.

“At Organon, 70% of the board are female. That’s higher than any S&P 500 healthcare company,” she said proudly. “[Gender equity] is not a female challenge – it’s all of us in the society facing that challenge…and it’s on all of us to build a great future.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Health Industry Hub | March 14, 2025 |

Over a third of Australian adults live with obesity, and the National Obesity Strategy estimates the direct and indirect costs […]

More


News & Trends - Pharmaceuticals

Astellas secures new indication for prostate cancer drug

Astellas secures new indication for prostate cancer drug

Health Industry Hub | March 14, 2025 |

Astellas Xtandi (enzalutamide) is now TGA registered for a new indication for patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with […]

More


News & Trends - MedTech & Diagnostics

Stakeholder calls intensify as government stalls on genetic discrimination ban

Stakeholder calls intensify as government stalls on genetic discrimination ban

Health Industry Hub | March 14, 2025 |

Calls have intensified for the federal government to honour its commitment to outlaw genetic discrimination in life insurance, as stakeholders […]

More


News & Trends - MedTech & Diagnostics

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Health Industry Hub | March 13, 2025 |

As Australia marks World Kidney Day, the stark reality is that one in three adults is at risk of chronic […]

More


This content is copyright protected. Please subscribe to gain access.